secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0001688757-23-000079
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Establishment Labs Q3 revenue $38.5M (+0.8% YoY); net loss widens to $29.3M; cuts 2023 guidance to ~$165M
--------------------------------------------------------------------------------

- Revenue $38.5M (+0.8% YoY); net loss $29.3M vs $18.6M; operating loss $21.0M vs $10.5M.
- 2023 revenue guidance lowered to ~$165M (up 2% over 2022); China approval removed from forecasts.
- Cash $52.2M at Sep 30; cash burn $14.2M since Dec 31, partially offset by Apr follow-on offering.
- FDA clearance of Motiva Flora SmoothSilk Tissue Expander on Oct 13; Mia Femtech 2-year data shows no capsular contracture.
- Reaffirms $500M revenue target for 2026 despite near-term demand softness.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000168875723000079/0001688757-23-000079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000168875723000079/esta-20231107.htm
  HTML page:      https://secwatch.observer/filing/0001688757-23-000079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer